1. Search Result
Search Result
No matches for "

57116

" within the MedChemExpress (MCE) catalog. Here are the results you might be looking for.

22

Inhibitors & Agonists

1

Inhibitory Antibodies

7

Antibodies

12

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-177555

    Influenza Virus Endonuclease Infection
    AV5116 is a cap-dependent endonuclease inhibitor (CENI) that binds to the active site of the cap-dependent endonuclease (CEN) located in the N-terminal domain of the polymerase acidic. AV5116 exhibits potent inhibitory activity against influenza viruses (influenza A, B, and C viruses). AV5116 can be used for the study of influenza virus infections .
    AV5116
  • HY-109544

    MY-5116

    Histamine Receptor Inflammation/Immunology
    Repirinast (MY-5116) is an orally active anti-allergic agent. Repirinast inhibits histamine release. Repirinast can be used in the research of bronchial asthma .
    Repirinast
  • HY-A0147A

    OPC-17116 hydrochloride; dl-Grepafloxacin hydrochloride

    Antibiotic Bacterial Infection
    Grepafloxacin (OPC-17116) hydrochloride is an oral actively fluoroquinolone antibiotic with potent activity against community-acquired respiratory pathogens including Streptococcus pneumonia. Grepafloxacin hydrochloride has high tissue penetration and a promising pharmacodynamic profile .
    Grepafloxacin hydrochloride
  • HY-144347

    CXCR Infection Cancer
    HF51116 is a potent antagonist of CXCR4. HF51116 strongly antagonizes SDF-1α-induced cell migration, calcium mobilization, and CXCR4 internalization. HF51116 inhibits HIV-1 infection via CXCR4. HF51116 has the potential for the research of HIV-1 infection, hematopoietic stem cell mobilization, and cancer metastasis .
    HF51116
  • HY-18714

    Others Cancer
    BRD7116 is a cell-non-autonomous inhibitor of leukemic stem cells (LSCs). BRD7116, without directly contacting LSCs, can inhibit LSCs merely by altering the microenvironment. BRD7116 also has any cell-autonomous effects on LSCs and induces transcriptional changes consistent with myeloid differentiation. BRD7116 can be used for the study of leukemia .
    BRD7116
  • HY-A0147

    OPC-17116; dl-Grepafloxacin

    Antibiotic Bacterial Infection
    Grepafloxacin (OPC-17116) is an oral actively fluoroquinolone antibiotic with potent activity against community-acquired respiratory pathogens including Streptococcus pneumonia. Grepafloxacin has high tissue penetration and a promising pharmacodynamic profile .
    Grepafloxacin
  • HY-123747A

    5-HT Receptor Neurological Disease
    SC-53116 hydrochloride is a selective 5-HT4 receptor agonist with EC50 at 23 nM .
    SC-53116 hydrochloride
  • HY-123747

    5-HT Receptor Neurological Disease
    SC-53116 is a selective 5-HT4 receptor agonist with EC50 at 23 nM .
    SC-53116
  • HY-R03261

    MicroRNA Cancer
    mmu-miR-5116 mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    mmu-miR-5116 mimic
    mmu-miR-5116 mimic
  • HY-R03942

    MicroRNA Cancer
    mmu-miR-7116-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    mmu-miR-7116-5p mimic
    mmu-miR-7116-5p mimic
  • HY-RI03942A

    MicroRNA Cancer
    mmu-miR-7116-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    mmu-miR-7116-5p antagomir
    mmu-miR-7116-5p antagomir
  • HY-RI03941

    MicroRNA Cancer
    mmu-miR-7116-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    mmu-miR-7116-3p inhibitor
    mmu-miR-7116-3p inhibitor
  • HY-RI03942

    MicroRNA Cancer
    mmu-miR-7116-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    mmu-miR-7116-5p inhibitor
    mmu-miR-7116-5p inhibitor
  • HY-RI03941A

    MicroRNA Cancer
    mmu-miR-7116-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    mmu-miR-7116-3p antagomir
    mmu-miR-7116-3p antagomir
  • HY-117488

    (S)-OPC-17116; (S)-dl-Grepafloxacin

    Bacterial Infection
    (S)-Grepafloxacin ((S)-OPC-17116) is the S-enantiomer of Grepafloxacin (HY-A0147) .
    (S)-Grepafloxacin
  • HY-R03261A

    MicroRNA Cancer
    mmu-miR-5116 agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    mmu-miR-5116 agomir
    mmu-miR-5116 agomir
  • HY-RI03261

    MicroRNA Cancer
    mmu-miR-5116 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    mmu-miR-5116 inhibitor
    mmu-miR-5116 inhibitor
  • HY-RI03261A

    MicroRNA Cancer
    mmu-miR-5116 antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    mmu-miR-5116 antagomir
    mmu-miR-5116 antagomir
  • HY-R03941

    MicroRNA Cancer
    mmu-miR-7116-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    mmu-miR-7116-3p mimic
    mmu-miR-7116-3p mimic
  • HY-R03942A

    MicroRNA Cancer
    mmu-miR-7116-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    mmu-miR-7116-5p agomir
    mmu-miR-7116-5p agomir
  • HY-R03941A

    MicroRNA Cancer
    mmu-miR-7116-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    mmu-miR-7116-3p agomir
    mmu-miR-7116-3p agomir
  • HY-P991825

    Integrin Inflammation/Immunology
    Anti-Mouse CD18 Antibody (C71/16) reacts with an epitope on mouse CD18. CD18 is the Integrin β2 chain. Recommend Isotype Controls: Rat IgG1 kappa, Isotype Control (HY-P99979) .
    Anti-Mouse CD18 Antibody (C71/16)

Inquiry Online

Submit your filled information, we will contact you soon.

Salutation: * Country or Region:
* Applicant Name: * Organization Name:
* Department:    
* Email Address: * Product Name:
Cat. No.: * Requested quantity:
* Phone Number:    
Remarks:

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: